Determination of imipenem efflux-mediated resistance in Acinetobacter spp., using an efflux pump inhibitor. 2019

Ghazale Amiri, and Maryam Abbasi Shaye, and Masoumeh Bahreini, and Asghar Mafinezhad, and Kiarash Ghazvini, and Mohammad Reza Sharifmoghadam
Deparment of Biology, Faculty of Science, Ferdowsi University of Mashhad, Mashhad, Iran.

OBJECTIVE In recent years, reports of Acinetobacter strains resistant to all known antibiotics have caused a great concern in medical communities. Overexpression of efflux pumps is one of the major causes of resistance in bacteria. The aim of this study was to investigate the role of efflux pumps in conferring resistance to imipenem in clinically important Acinetobacter spp; Acinetobacter baumannii and Acinetobacter lwoffii. METHODS A total number of 46 clinical Acinetobacter isolates, including 33 A. baumannii and 13 A. lwoffii isolates, previously collected from Shahid Kamyab and Ghaem hospitals of Mashhad, Iran were used in this study. Imipenem susceptibility testing was carried out by the disc diffusion method. Imipenem minimum inhibitory concentration (MIC) for resistant Acinetobacter isolates were determined both in the presence and absence of the efflux pumps inhibitor, carbonyl cyanide 3-chlorophenylhydrazone (CCCP). RESULTS Resistance to imipenem was observed in 38 isolates including 30 A. baumannii and 8 A. lwoffii isolates. Experiments in the presence of CCCP showed a 2 to 16384 fold reduction in imipenem MICs in 14 A. baumannii and 2 A. lwoffii isolates. CONCLUSIONS The results obtained showed high levels of resistance to imipenem and contribution of efflux pumps in conferring resistance in both Acinetobacter species in this study. Moreover, imipenem efflux mediated resistance highlights the importance of this mechanism not only in A. baumannii but also in non-baumannii Acinetobacter Spp. which have been neglected in antibiotic resistance studies.

UI MeSH Term Description Entries

Related Publications

Ghazale Amiri, and Maryam Abbasi Shaye, and Masoumeh Bahreini, and Asghar Mafinezhad, and Kiarash Ghazvini, and Mohammad Reza Sharifmoghadam
September 2009, Current microbiology,
Ghazale Amiri, and Maryam Abbasi Shaye, and Masoumeh Bahreini, and Asghar Mafinezhad, and Kiarash Ghazvini, and Mohammad Reza Sharifmoghadam
March 2011, Antimicrobial agents and chemotherapy,
Ghazale Amiri, and Maryam Abbasi Shaye, and Masoumeh Bahreini, and Asghar Mafinezhad, and Kiarash Ghazvini, and Mohammad Reza Sharifmoghadam
June 2015, Infection & chemotherapy,
Ghazale Amiri, and Maryam Abbasi Shaye, and Masoumeh Bahreini, and Asghar Mafinezhad, and Kiarash Ghazvini, and Mohammad Reza Sharifmoghadam
February 2005, Antimicrobial agents and chemotherapy,
Ghazale Amiri, and Maryam Abbasi Shaye, and Masoumeh Bahreini, and Asghar Mafinezhad, and Kiarash Ghazvini, and Mohammad Reza Sharifmoghadam
November 2007, Antimicrobial agents and chemotherapy,
Ghazale Amiri, and Maryam Abbasi Shaye, and Masoumeh Bahreini, and Asghar Mafinezhad, and Kiarash Ghazvini, and Mohammad Reza Sharifmoghadam
June 2021, Antimicrobial agents and chemotherapy,
Ghazale Amiri, and Maryam Abbasi Shaye, and Masoumeh Bahreini, and Asghar Mafinezhad, and Kiarash Ghazvini, and Mohammad Reza Sharifmoghadam
July 2012, Annals of medical and health sciences research,
Ghazale Amiri, and Maryam Abbasi Shaye, and Masoumeh Bahreini, and Asghar Mafinezhad, and Kiarash Ghazvini, and Mohammad Reza Sharifmoghadam
January 2016, Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology],
Ghazale Amiri, and Maryam Abbasi Shaye, and Masoumeh Bahreini, and Asghar Mafinezhad, and Kiarash Ghazvini, and Mohammad Reza Sharifmoghadam
April 2017, Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences,
Ghazale Amiri, and Maryam Abbasi Shaye, and Masoumeh Bahreini, and Asghar Mafinezhad, and Kiarash Ghazvini, and Mohammad Reza Sharifmoghadam
May 2009, Journal of clinical microbiology,
Copied contents to your clipboard!